Covidien — Merger or Acquisition (August 2014)
25 slides from Covidien's merger presentation, Aug 8, 2014
Slide 1: Town Hall Meeting
Town Hall Meeting August 8, 2014 Omar Ishrak Chairman and CEO Medtronic, Inc. Filed by Medtronic, Inc. (SEC File No.: 001-07707) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: Covidien plc Form
Slide 2: Medtronic to Acquire Covidien
Medtronic to Acquire Covidien Creates the premier global medical technology and services company with unmatched breadth and patient reach
Slide 3: The Medtronic Mission: A Shared Sense of Purpose
The Medtronic Mission: A Shared Sense of Purpose To contribute to human welfare…alleviate pain, restore health, and extend life… To direct our growth in the areas of maximum strength and ability…to continuously build on these areas through education and knowledge… To strive without reserve for the g
Slide 4: Universal Healthcare Needs
Improve Clinical Outcomes Expand Access Optimize Cost and Efficiency Universal Healthcare Needs
Slide 5: Strategies to Address Healthcare Needs
Economic Value Globalization Strategies Therapy Innovation Universal HC needs Improve clinical outcomes Expand access Optimize cost and efficiency Strategies to Address Healthcare Needs
Slide 6: Joe Almeida, Chairman, President & CEO, Covidien
Joe Almeida Chairman, President & CEO, Covidien • President and CEO since 2011 • Chairman since 2012 • 17 years with Covidien • 23 years industry experience • Chairman, AdvaMed Board of Directors • Partners in Health, Business Roundtable • Board Member, State Street Bank • B.S. in Mechanical Enginee
Slide 7: Medtronic | Covidien
&} Medtronic | E ai covipien
Slide 8: Strategic Fit
Strategic Fit
Slide 9: Combination Results in Strategic Diversification
Combination Results in Strategic Diversification Surgical Solutions Respiratory & Patient Care Surgical Solutions Respiratory & Patient Care
Slide 10: A Strong Strategic Fit
Delivering strong launch cadence of meaningful therapies and procedures Addressing the inequities in healthcare access globally Becoming a leader in value-based healthcare by incorporating EV into our DNA Uniquely positioned to expand our industry- leading franchises through our three differentiated
Slide 11: Three Key Benefits for Medtronic and Covidien
Three Key Benefits for Medtronic and Covidien Therapy Innovation Therapy Innovation 1. Strengthen and enhance Peripheral Vascular and Neuroscience portfolios 2. Leverage adjacencies in Medtronic Surgical Technologies and Covidien Surgical Solutions 3. Accelerate market adoption of early stage Covidi
Slide 12: Combined Company Immediately Accelerates Ability to Expand Global Access
Combined Company Immediately Accelerates Ability to Expand Global Access countries 150 + locations 300 + combined EM revenue $3.7B Broader presence facilitates more rapid expansion Covidien products such as surgical tools and capital equipment are adopted earlier in hospitals, becoming a base for Me
Slide 13: Opportunities to Become Robust Integrated Health Solutions Partner
Cath Lab Managed Services (Europe) Cardiac & Vascular Line Administrator (U.S.) General Surgery Line Administrator (U.S.) General Surgery Managed Services (Europe) Opportunities to Become Robust Unmatched Integrated Health Solutions Partner Economic Value Cardiocom Covidien Sensors Value primarily r
Slide 14: Integration Guidelines
Integration Guidelines
Slide 15: Guiding Principles for Integration
Guiding Principles for Integration • Continue to act as independent companies until transaction close • Keep focus and protect current business momentum in our respective companies • Plan for integration now to be ready for Day 1 post-close • Focus on creating lasting value beyond stated cost synerg
Slide 16: Integration Team Structure
Integration Team Structure Medtronic Medtronic Geoff Martha Bill Burke Medtronic Steering Committee Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Medtronic Cross-functional teams Commercial teams Functional teams Med
Slide 17: Combined Impact
Combined Impact
Slide 18: Accelerating Covidien Early Stage Therapies
Accelerating Covidien Early Stage Therapies Interventional Lung: For Lung Cancer Interventional GI (Barrett's): For Barrett's Esophagus (pre-cancerous) Stroke: SWIFT PRIME Clinical Trial Open to Minimally Invasive Surgery: e.g. Bariatric Minimally Invasive Surgery Capnography: CO 2 Monitoring
Slide 19: Transforming Healthcare Around the World to Improve More Lives Together
Transforming Healthcare Around the World to Improve More Lives Together: Every seconds $27 Billion Healthcare Leader 87,000+ Employees Life-Changing Impact for Millions of Patients
Slide 20: Q&A
Q&A ?
Slide 21: Disclaimers
Disclaimers NO OFFER OR SOLICITATION This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pur
Slide 22: Disclaimers (cont'd)
Disclaimers (cont’d) PARTICIPANTS IN THE SOLICITATION Medtronic, New Medtronic and Covidien and certain of their respective directors and executive officers and employees may be considered participants in the solicitation of proxies from the respective shareholders of Medtronic and Covidien in respe
Slide 23: Disclaimers (cont'd)
Disclaimers (cont’d) Cautionary Statement Regarding Forward-Looking Statements Statements contained in this communication that refer to New Medtronic’s, Medtronic's and/or Covidien’s estimated or anticipated future results, including estimated synergies, or other non-historical facts are forward-loo
Slide 24: Disclaimers (cont'd)
Disclaimers (cont’d) Statement Required by the Irish Takeover Rules The directors of Medtronic accept responsibility for the information contained in this document. To the best of the knowledge and belief of the directors of Medtronic (who have taken all reasonable care to ensure that such is the ca
Slide 25: Town Hall Meeting
Town Hall Meeting Omar Ishrak Chairman and CEO Medtronic, Inc.